Cramer is bullish on Sunrise Senior Living (SZR) for a long-term investment. The average person with Alzheimer’s disease lives 8 years to 10 years after diagnosis, and some live as along as 20 years, he said. With the number of cases of Alzheimer’s disease growing each year, that means big growth for Sunrise, which caters to Alzheimer’s patients. Cramer likes the fact that 90% of SZR revenues come from private insurance companies.